ImmuCell Corporation
ICCC
$9.67
-$0.10-1.02%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.04M | 2.32M | 1.76M | -271.70K | -2.16M |
| Total Depreciation and Amortization | 2.73M | 2.70M | 2.69M | 2.70M | 2.69M |
| Total Amortization of Deferred Charges | 54.40K | 62.00K | 43.20K | 43.20K | 42.60K |
| Total Other Non-Cash Items | 2.78M | -20.40K | 112.30K | 166.60K | 191.20K |
| Change in Net Operating Assets | -2.05M | -3.07M | -2.08M | -1.12M | -406.50K |
| Cash from Operations | 2.48M | 1.99M | 2.53M | 1.51M | 357.90K |
| Capital Expenditure | -1.25M | -1.27M | -768.90K | -724.40K | -465.70K |
| Sale of Property, Plant, and Equipment | 36.10K | 31.10K | 29.20K | 4.50K | 4.50K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1.21M | -1.24M | -739.60K | -719.90K | -461.20K |
| Total Debt Issued | 801.30K | 801.30K | -- | -- | -- |
| Total Debt Repaid | -2.28M | -2.26M | -1.50M | -1.49M | -1.47M |
| Issuance of Common Stock | 349.30K | 888.60K | 4.58M | 4.67M | 4.65M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -82.50K | -98.70K | -194.90K | -334.80K | -296.80K |
| Cash from Financing | -1.21M | -668.80K | 2.88M | 2.85M | 2.88M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 48.50K | 77.50K | 4.67M | 3.64M | 2.78M |